Ireland: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

European Medicines Agency SME Status – A Quick Guide

The European Medicines Agency offers special status to micro, small and medium-sized enterprises developing medicines, providing financial incentives, translation services, and regulatory guidance to foster innovation. Companies meeting specific employee and financial thresholds can access fee reductions, deferred payments, and expert support through the EMA's SME office.

Ireland Healthcare

AC

Arthur Cox

Life Sciences And Healthcare M&A 2025: A Year In Review

This report examines how deal activity in the life sciences and healthcare sector performed during 2025, highlighting key trends, significant transactions and emerging themes shaping the market. The report also looks ahead to 2026, considering the factors likely to influence M&A activity in Ireland in the year ahead.

Ireland Healthcare

AC

Arthur Cox

Assisted Decision-Making: New Act Ensures Certainty Ahead Of Deadline

The Assisted Decision-Making (Capacity) (Amendment) Act 2026 was enacted on 31 March 2026 and addresses a practical issue that has arisen in reviewing existing wardship cases under the timeframe provided for in the existing legal framework.

Ireland Healthcare

AC

Arthur Cox

Pricing And Reimbursement Of Medicines In Ireland: New Framework Agreement 2026-2029 Published

Following the announcement in January that agreement had been reached, the full text of the Framework Agreement on the Supply and Pricing of Medicines ("FASPM")...

Ireland Healthcare

AC

Arthur Cox

MDR/IVDR: Overview Of The Commission’s December 2025 Proposed Amendments

Ireland Healthcare

AC

Arthur Cox

Movement On The Pharma Package: Formal Adoption Within Reach

Ireland Healthcare

AC

Arthur Cox

Life Sciences: Update On National Strategy; Framework Agreements On Pricing And Supply Of Medicines

Ireland Healthcare

MF

McCann Fitzgerald

Clinical Trials Regulation In Ireland And The EU: Key Updates Shaping 2025 And 2026

European Union Healthcare

AC

Arthur Cox

Residential Healthcare – Who Pays Rates?

Ireland Healthcare

AC

Arthur Cox

Spill The Beans – New Information Powers For The Agri-Food Regulator

Ireland Healthcare

MF

McCann Fitzgerald

EU Critical Medicines Act: What Life Sciences Companies Need To Know

Ireland Healthcare

MF

McCann Fitzgerald

EHDS Regulation: Secondary Use Of Electronic Health Data

Ireland Healthcare

MF

McCann Fitzgerald

EU Agrees Landmark Reform Of Pharmaceutical Legislation

Ireland Healthcare

MF

McCann Fitzgerald

Turning Europe Into A Biotech Powerhouse: Commission Unveils Biotech Act And Regulatory Simplification For Devices

Ireland Healthcare

MF

McCann Fitzgerald

Blocking Bad-Faith DSARs: The Brillen Rottler Ruling

Ireland Privacy

MF

McCann Fitzgerald

The EU Pay Transparency Directive (Podcast)

Ireland Employment

AC

Arthur Cox

Horizon Scanner: Energy Planning Infrastructure And Construction April 2026 - Construction And Engineering

Ireland Real Estate

AC

Arthur Cox

EDPB 2025 Annual Report: Recent Trends

Ireland Privacy

MF

McCann Fitzgerald

Navigating Public Inquiries (Part 3): Process And Oral Hearings

Ireland Litigation

MF

McCann Fitzgerald

See more

Food and Drugs Law

Pro = Active? CJEU Asked To Decide

HGF operates a comprehensive network of intellectual property offices spanning major cities across the United Kingdom, Europe, and Ireland.

HL

HGF Ltd

MDR/IVDR: Overview Of The Commission’s December 2025 Proposed Amendments

On 16 December 2025, the European Commission announced its new Health Package. One aspect of this expansive reform included the proposal for a regulation to simplify rules...

Ireland Healthcare

AC

Arthur Cox

Proposed EU-wide Restriction PFAS: Consultation To Be Held

The proposed restriction of PFAS across the EU continues to progress and could potentially impact various sectors, including for example aerospace and defence, automotive, aviation, food contact materials, textiles, leather and apparel, construction and household products, electronics, firefighting, food processing, and medical articles.

Ireland Environment

M

Matheson

Clinical Trials Regulation In Ireland And The EU: Key Updates Shaping 2025 And 2026

European Union Healthcare

AC

Arthur Cox

The EU Platform Work Directive: What It Is And Why It Matters

Ireland Employment

AC

Arthur Cox

Spill The Beans – New Information Powers For The Agri-Food Regulator

Ireland Healthcare

MF

McCann Fitzgerald

EU Critical Medicines Act: What Life Sciences Companies Need To Know

Ireland Healthcare

MF

McCann Fitzgerald

EHDS Regulation: Secondary Use Of Electronic Health Data

Ireland Healthcare

MF

McCann Fitzgerald

Charting Ireland's Life Sciences Strategy: Scope And Policy Priorities

Ireland Healthcare

MF

McCann Fitzgerald

See more

Life Sciences, Biotechnology & Nanotechnology

European Medicines Agency SME Status – A Quick Guide

The European Medicines Agency offers special status to micro, small and medium-sized enterprises developing medicines, providing financial incentives, translation services, and regulatory guidance to foster innovation. Companies meeting specific employee and financial thresholds can access fee reductions, deferred payments, and expert support through the EMA's SME office.

Ireland Healthcare

AC

Arthur Cox

EU AI Act Omnibus Deal Reached: Postponed Deadlines, Watermarking Compromise, And The Nudificiation Prohibition

The text remains subject to formal endorsement by both institutions and to legal-linguistic revision before adoption, with publication in the Official Journal expected ahead of the original...

Ireland Technology

WF

William Fry

Life Sciences And Healthcare M&A 2025: A Year In Review

This report examines how deal activity in the life sciences and healthcare sector performed during 2025, highlighting key trends, significant transactions and emerging themes shaping the market. The report also looks ahead to 2026, considering the factors likely to influence M&A activity in Ireland in the year ahead.

Ireland Healthcare

AC

Arthur Cox

NIS 2 – A New Era For The Life Sciences Sector

Ireland Technology

M

Matheson

Pricing And Reimbursement Of Medicines In Ireland: New Framework Agreement 2026-2029 Published

Ireland Healthcare

AC

Arthur Cox

Movement On The Pharma Package: Formal Adoption Within Reach

Ireland Healthcare

AC

Arthur Cox

Life Sciences: Update On National Strategy; Framework Agreements On Pricing And Supply Of Medicines

Ireland Healthcare

MF

McCann Fitzgerald

Clinical Trials Regulation In Ireland And The EU: Key Updates Shaping 2025 And 2026

European Union Healthcare

AC

Arthur Cox

EU Critical Medicines Act: What Life Sciences Companies Need To Know

Ireland Healthcare

MF

McCann Fitzgerald

See more

Healthcare

European Medicines Agency SME Status – A Quick Guide

The European Medicines Agency offers special status to micro, small and medium-sized enterprises developing medicines, providing financial incentives, translation services, and regulatory guidance to foster innovation. Companies meeting specific employee and financial thresholds can access fee reductions, deferred payments, and expert support through the EMA's SME office.

Ireland Healthcare

AC

Arthur Cox

When Does The Clock Start? Key Takeaways From The CJEU’s Recent Sanofi Pasteur Judgment

Less than a year before the transposition of the revised Product Lability Directive1, the Court of Justice of the European Union (“CJEU”) has provided some welcome clarification on the application of the limitation periods...

Ireland Litigation

MF

McCann Fitzgerald

Life Sciences And Healthcare M&A 2025: A Year In Review

This report examines how deal activity in the life sciences and healthcare sector performed during 2025, highlighting key trends, significant transactions and emerging themes shaping the market. The report also looks ahead to 2026, considering the factors likely to influence M&A activity in Ireland in the year ahead.

Ireland Healthcare

AC

Arthur Cox

Assisted Decision-Making: New Act Ensures Certainty Ahead Of Deadline

Ireland Healthcare

AC

Arthur Cox

Pricing And Reimbursement Of Medicines In Ireland: New Framework Agreement 2026-2029 Published

Ireland Healthcare

AC

Arthur Cox

MDR/IVDR: Overview Of The Commission’s December 2025 Proposed Amendments

Ireland Healthcare

AC

Arthur Cox

Urban Wastewater Treatment Directive – Irish Transposition

Ireland Environment

M

Matheson

Life Sciences: Update On National Strategy; Framework Agreements On Pricing And Supply Of Medicines

Ireland Healthcare

MF

McCann Fitzgerald

Clinical Trials Regulation In Ireland And The EU: Key Updates Shaping 2025 And 2026

European Union Healthcare

AC

Arthur Cox

See more

Latest Videos

See more

What Regulatory Challenges Are Facing The Life Sciences Sector? (Video)

WF

William Fry

Launch Of Our Medical Device Publication (Video)

WF

William Fry

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More